General American Investor

Broadcom is a leading designer, developer, and global supplier of a diverse array of analog and digital semiconductor solutions. Headquartered in San Jose, California, the company offers an extensive product portfolio that includes over 6,500 items targeted at various key markets such as wireless communications, wired infrastructure, industrial and automotive electronics, and consumer computing peripherals. Its products are integral to a wide range of applications, including cellular phones, data networking, telecommunications, enterprise storage, renewable energy, and factory automation. Broadcom's offerings range from simple discrete devices to complex subsystems that incorporate multiple device types and firmware, as well as mechanical hardware for optoelectronic and capacitive sensors, contributing to the scalability, agility, and security of business operations.

Kindred Biosciences is a veterinary biotechnology company based in San Francisco, California, that specializes in developing innovative biologics for companion animals, specifically dogs, cats, and horses. The company focuses on creating therapies by identifying compounds and targets previously validated for safety and efficacy in humans, thus adapting these therapeutics for animal use. Kindred Biosciences aims to enhance the lives of pets through its diverse pipeline of novel biologics across various therapeutic classes. With established biologics manufacturing capabilities and a robust intellectual property portfolio, the company is committed to providing pets with safe and effective medical treatments akin to those available for humans. Incorporated in 2012, Kindred Biosciences strives to revolutionize veterinary medicine by delivering advanced therapeutics to improve animal health.